HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech

Celltrion

1
Articles
Deal Party
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
1.55
Relevance Score

Coverage Timeline

April 2026
Biosimilars Beyond Humira: New Pressures and Unwritten Rules for Stelara, Keytruda, and Eylea in 2026 Pipeline Deal Party
Apr 11, 2026
Alvotech, Celltrion, and others are all cutting royalty checks to J&J.
Related Companies
Alvotech
1 shared
Fresenius Kabi
1 shared
Samsung Bioepis
1 shared
Sandoz International GmbH
1 shared
Regeneron Pharmaceuticals, Inc.
1 shared
Johnson & Johnson
1 shared
Amgen Inc.
1 shared
Merck & Co., Inc.
1 shared